Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015

 Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 17th May, 2024, at Crowne Plaza Today, Plot No.1, Community Centre, Okhla -I, New Delhi-110020, approved the following businesses: a. Audited Financial Results (Consolidate & Standalone) for the Fourth quarter and financial year ended on 31st March 2024. b. Recommendation of Dividend of Rs. 3 (Three Rupees) per Equity Shares (60%) of Rs. 5 each for the Financial Year 2023-24, subject to the approval of shareholders. c. Any Other Item. The Meeting was started at 10.30 am and concluded on 1:30 pm. Kindly take a note of the same for your further needful and oblige us.
17-05-2024
Bigul

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Monday, 20th May, 2024 at 4.00 p.m. (IST) for discussing the Audited Financial Results of the Company for the quarter and year ended 31st March, 2024. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting. This is for your information and record.
15-05-2024
Bigul

POLY MEDICURE LTD. - 531768 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Dear Sir/Madam, Pursuant to Regualtion 39(3) of SEBI(LODR), 2015, below mentioned share certificates of the Company was reported lost and after verification of all requisite documents, duplicate share certificates has been issued in lieu thereof, as per details mentioned. Name : MAYUR JAMNADAS VORA FOLIO NO. 0003178 OLD certificate No. 64 New Certificate No. 401 No. of share: 400
06-05-2024
Bigul

POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 17Th May,2024.

 POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, notice is hereby given that a meeting of the Board of Director of the Company will be held on Friday, the 17th May, 2024, inter alia to consider the following: a. To consider and approve the Audited Financial Results (Consolidated & Standalone) of the company for the financial year ended on 31st March, 2024. b. To consider recommendation of Final Dividend, If any, on the Equity Shares for the Financial year ended on 31st March, 2024. c. To transact any other matter which the Board may deem fit. In continuation of our intimation regarding closure of trading window vide letter dated 31st March, 2024, the Trading Window for dealing in securities of the company shall remain closed till 19th May, 2024.
02-05-2024
Bigul

POLY MEDICURE LTD. - 531768 - Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024.

 Pursuant to the Regulation 40(9) of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the certificate issued by the Practicing Company Secretary for the financial year ended on 31st March, 2024.
22-04-2024
Bigul

POLY MEDICURE LTD. - 531768 - Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 7(3) of the Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that all activities in relation to share transfer facility are maintained by the Company;s Registrar and Share Transfer Agent, viz, Mas Services Limited, a SEBI approved category-I, Registrar & Transfer Agent, registered with SEBI (R.NO. INR000000049) during the period from 01st April, 2023 to 31st March, 2024 (both days inclusive.
11-04-2024
Bigul

POLY MEDICURE LTD. - 531768 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In terms of Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018, we enclose herewith confirmation certificate received from M/s Mas Services Limited, Registrar & Share Transfer Agent of the Company for the Quarter ended 31st March, 2024.
09-04-2024
Bigul

POLY MEDICURE LTD. - 531768 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 pursuant to Regulation 39(3) of SEBI(LODR), 2015, we hereby inform that the registrar and transfer agent of the company MAS Services Limited has received request from the following shareholder for issue of duplicate bshare certificate in respect of below mentioned shares. We are in process of issuing duplicate share certificate after compliance of the required formalities. Namr of Shareholder: Mayur Jamnadas Vora 1st Joint Holder : Jamnadas Hirachand Vora(Deceased) 2nd Joint Holder: N.A. Folio No: 0003178 Share Certificate No : 00000064 Distinctive No: 000409805-000410204 No. of Equity Share: 400.
02-04-2024
Bigul

POLY MEDICURE LTD. - 531768 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) if SEBI(LODR), 2015, we hereby inform you that the Registrar and transfer agent of the company Mas Services Ltd has received a request from the following shareholder for issue of duplicate share certificate in respect of the below mentioned shares. we are in the process of isssuing of duplicate share certificate after compliance of the required formalities. Name of the shareholder: Mayur jamnadas vora, 1st Joint Shareholder: Jamnadas hirachand vora (deceased) 2nd joint Shareholder : NA. Folio No. 0003178 share certicate no. 00000064 Distinctice No. 000409805 - 000410204 No. of Equity share: 400.
02-04-2024
Bigul

POLY MEDICURE LTD. - 531768 - Closure of Trading Window

 Dear Sir/Madam, It may please be noted that in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading)(Amendment) Regulations, 2018 read with clarification given by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated 02.04.2019 and NSE letter ref no.: NSE/CML/2019/11 dated 02.04.2019 read with Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Monday, 1st April, 2024 till the end of 48 hours after the declaration of Financial Result for the quarter and year ended 31st March, 2024.
30-03-2024
Next Page
Close

Let's Open Free Demat Account